The 8th Annual Cherry Blossom Ocular Pathology Course

February 7, 2025 to February 8, 2025

The purpose of the course is designed to meet the educational needs of a staff ophthalmologist and ophthalmic resident and also to provide a primer for staff pathologists and residents who have an interest in ophthalmic pathology. The goal is to fulfill a gap in ophthalmic pathology training nationwide since the unfortunate closure of the Armed Forces Institute of Pathology in 2011.

Goals:

1. Provide an understanding of ocular embryology;
2. Provide an understanding of ocular tumors to include retinoblastoma, ocular melanoma and choroidal metastases;
3. Review the pathology of ocular surface neoplasia and lymphoma;
4. Review the pathology of glaucomatous disorders;
5. Review the pathology of eyelid and adnexal tumors;
6. Review optic nerve pathology;
7. Review the nuances of corneal histopathology;
8. Review pediatric ocular tumors;
9. Review orbital and lacrimal gland tumors and to review the pathology of ocular inflammatory and infectious diseases;
10. Review the histopathology of ocular inflammatory and parasitic diseases.
 

a) the importance of good communication between clinician/surgeon and pathologist;
b) instances in which the pathologist makes the diagnosis that eluded the clinicians;
c) instances in which the pathologist makes a diagnosis that is of not only ocular but also systemic significance;
d) the importance for the clinician of questioning the initial diagnosis when some clinical features don't fit and when the patient isn't responding to therapy.

To illustrate these themes, some of the cases will be classic cases, others will be somewhat atypical presentations of not-uncommon diseases, and others may be examples of more rare conditions (but still ones that the residents/faculty should know).

Target Audience

This activity is intended to meet the educational needs of the healthcare team including but not limited to:
  • Physicians
  • Residents
  • Medical Students
  • Pharmacists
  • Physician assistants
  • Nurses
  • Other Healthcare Professionals

Learning Objectives

a) the importance of good communication between clinician/surgeon and pathologist;
b) instances in which the pathologist makes the diagnosis that eluded the clinicians;
c) instances in which the pathologist makes a diagnosis that is of not only ocular but also systemic significance;
d) the importance for the clinician of questioning the initial diagnosis when some clinical features don't fit and when the patient isn't responding to therapy.
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.00 ACPE Pharmacy technician
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 18.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 18.00 Completion
Course opens: 
02/07/2025
Course expires: 
02/07/2028
Event starts: 
02/07/2025 - 8:00am EST
Event ends: 
02/08/2025 - 5:00pm EST

Friday, February 7, 2025
0800-0805. Introduction Wroblewski MD
0805-1000 Cases in Ophthalmic Pathology and Dermatopathology Stagner MD
1000-1100 Ocular Lymphomas Chan MD Virtual
1100-1200 Ocular Genetics Brooks MD PhD Virtual
1200-1230 Lunch
1230-1400 Conjunctiva Mudhar MD Virtual
1400-1500 Pediatric Ocular Pathology Chevez-Barrios MD Virtual
1500-1600. Immunohistochemistry and Patterns of Disease. Proia MD PhD.
Virtual 1600-1700 Optic Nerve Sabet MD Virtual
1700-1830 Retina Dubovy Virtual

Saturday, February 8, 2025
0900-1100 Cornea and Orbit Eberhart MD PhD Virtual
1100-1300 Phakomatoses, Iris, Optic Nerve Rodriquez MD Virtual
1300-1400 Lunch
1400-1600 Ocular Tumors Milman MD Virtual
1600-1700 Ophthalmic Syndromes and Ocular Inflammation Wroblewski MD
1700-1800 Glaucoma Edward MD Virtual TBD This lecture time may change
1800-1930. Orbit Elner MD PhD Virtual

Faculty & Disclosure
 
Planning Committee


Keith James J. Wroblewski, MD
George Washington University
Washington, DC

 
Faculty

 

  

 

 Brian P. Brooks, MD, PhD
National Eye Institute
Bethesda, Maryland

Patricia Chevez-Barrios, MD
Houston Methodist
Houston, Texas

Sander R. Dubovy, MD
Bascom Palmer Eye Institute
Miami, Florida

Charles G. Eberhart, MD, PhD
Wilmer Eye Institute
Baltimore, Maryland

Deepak Edward, MD
University of Illinois
Chicago, Illinois

Victor M. Elner, MD, PhD
Kellogg Eye Center
Ann Arbor, Michigan

Tatyana Milman, MD
Wills Eye Hospital
Philadephia, PA

Alan Proia, MD, PhD
Duke University and Campbell University
Raleigh-Durham, NC

Fausto J. Rodriquez MD
University of California Los Angeles
Los Angeles, California

Sina Sabet, MD
Georgetown University
Washington, DC

Keith J. Wroblewski, MD
George Washington University
Washington, DC
 
 
Disclosure of Relevant Financial Relationships
In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE Activity.  An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
Disclosure Statement(s)
 
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Relevant Financial Relationships
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following planners, faculty, and others in control of educational content have relevant financial relationships with ineligible companies.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
[Insert name], [insert role] for this accredited CE activity, is [nature of relationship(s)] for [insert name of the ineligible company(ies)].
 
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
 

 

 

 

 
Accreditation Statements
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation Statement(s)
Physicians (CME)
 
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 18.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Ways to report CME Credit:
 
Other Healthcare Professionals (Attendance)
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance.  Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.

Available Credit

  • 1.00 ACPE Pharmacist
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.00 ACPE Pharmacy technician
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 18.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 18.00 Completion
Please login or register to take this course.

Registration Instructions

Please note that you must be logged in to complete the CE credit claim process. 

New Users

You must create a learner account prior to claiming CE credit. 

Click here to create a learner account

Click here to access additional instructions for creating a learner account

Returning Users

Click here to login and proceed with claiming CE credit.